Recruiting
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer
In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.
ClinicalTrials.gov IDNCT06858449
PhaseNA
Enrollment30
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Age20 Years – 89 Years
SexFEMALE
Conditions studied
Cancer, Breast Cancer
About this study
In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.
Interventions
- Dietary Supplement: Whey protein (20 grams) — 20 grams of whey protein
- Dietary Supplement: Whey protein (60 grams) — 60 grams of whey protein.
Primary outcomes
- Changes in muscle mass and fat mass (pounds) at completion of chemotherapy (Baseline and at program completion (within 4 weeks of exercise completion).)
Eligibility information
Inclusion Criteria:
1. Age 20-89 years
2. Women with a biopsy proven diagnosis of invasive carcinoma of the breast.
3. Women must undergo neoadjuvant chemotherapy for breast cancer treatment prior to surgery
4. Must be able to read and understand English and consent for themselves.
Exclusion Criteria:
1. Inability to get up and down off the ground or squat body weight
2. Inability to safely engage in group exercise sessions as deemed by study PI
3. Severe arthritic, joint, cardiovascular, musculoskeletal, or any other condition deemed by PI to be unsafe to engage in resistance training
4. Lactose intolerance
5. Cow's milk or whey protein allergy
6. Pregnant women
7. Males
Study locations
- Allegheny General Hospital, Pittsburgh, Pennsylvania 15212 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-17.